ACADIA Pharmaceuticals Reports First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. META

Go back to ACADIA Pharmaceuticals Reports First Quarter 2020 Financial Results

Acadia Pharma (ACAD) Misses Q1 EPS by 9c

May 7, 2020 4:44 PM EDT

Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.57), $0.09 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $90.1 million versus the consensus estimate of $91.51 million.

ACADIA entered 2020 with positive momentum. Successful execution of our commercial efforts led to continued strong... More